What is the catalog number for VEGFR2/KDR Mouse Monoclonal Antibody?

The catalog number for VEGFR2/KDR Mouse Monoclonal Antibody is orb18217.

What sizes are available for VEGFR2/KDR Mouse Monoclonal Antibody?

VEGFR2/KDR Mouse Monoclonal Antibody is available in the following size(s): 100 µg.

Is VEGFR2/KDR Mouse Monoclonal Antibody in stock?

VEGFR2/KDR Mouse Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

VEGFR2/KDR Mouse Monoclonal Antibody

Anti-VEGFR2/KDR Monoclonal Antibody. Tested in IHC applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

Vascular endothelial growth factor receptor 2; VEGFR-2; 2.7.10.1; Fetal liver kinase 1; FLK-1; Protein-tyrosine kinase receptor flk-1; CD309; Kdr; Flk1

UniProt

O08775

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

Recombinant human extracellular domain of VEGFR-2 (KDR) .

Target

Vascular endothelial growth factor receptor 2

Clonality

Monoclonal

Clone

BMFTX3

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cardiovascular Research, Cardiovascular Research; Cell Biology, Cell Biology, Metabolism Research, Microbiology, Protein Biochemistry, Signal Transduction, Stem Cell & Developmental Biology

Purification

Ascites

Concentration

Adding 1 ml of PBS buffer will yield a concentration of 100 μg/ml.

Dilution

Immunohistochemistry (Frozen Section), 1-2μg/ml, Human

Form

Lyophilized

Molecular Weight

426 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC

Host or Source

Mouse

Preservative

Mouse IgG in stabilizing components, 1.2% sodium acetate and 0.01mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.